BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29463166)

  • 1. Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor.
    Vesterinen T; Mononen S; Salmenkivi K; Mustonen H; Räsänen J; Salo JA; Ilonen I; Knuuttila A; Haglund C; Arola J
    Acta Oncol; 2018 Aug; 57(8):1109-1116. PubMed ID: 29463166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.
    Clay V; Papaxoinis G; Sanderson B; Valle JW; Howell M; Lamarca A; Krysiak P; Bishop P; Nonaka D; Mansoor W
    Clin Transl Oncol; 2017 May; 19(5):579-586. PubMed ID: 27848218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids.
    Swarts DR; Rudelius M; Claessen SM; Cleutjens JP; Seidl S; Volante M; Ramaekers FC; Speel EJ
    Histopathology; 2017 Feb; 70(3):412-422. PubMed ID: 27701763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive pathological and clinical features of lung carcinoids with high proliferation index.
    Marchiò C; Gatti G; Massa F; Bertero L; Filosso P; Pelosi G; Cassoni P; Volante M; Papotti M
    Virchows Arch; 2017 Dec; 471(6):713-720. PubMed ID: 28631159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Immunohistochemistry for Ki-67 and OTP on Small Biopsies of Pulmonary Carcinoid Tumors: Ki-67 Index Predicts Progression-free Survival and Atypical Histology.
    Naso JR; Jenkins SM; Roden AC; Yi ES; Lo YC; Bois MC; Maleszewski JJ; Aubry MC; Boland JM
    Am J Surg Pathol; 2024 Jun; 48(6):742-750. PubMed ID: 38584496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
    Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
    Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors.
    Walts AE; Ines D; Marchevsky AM
    Mod Pathol; 2012 Sep; 25(9):1258-64. PubMed ID: 22575865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.
    Cusumano G; Fournel L; Strano S; Damotte D; Charpentier MC; Galia A; Terminella A; Nicolosi M; Regnard JF; Alifano M
    Lung; 2017 Dec; 195(6):789-798. PubMed ID: 29022070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
    Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
    J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors.
    Vesterinen T; Leijon H; Mustonen H; Remes S; Knuuttila A; Salmenkivi K; Vainio P; Arola J; Haglund C
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2083-2093. PubMed ID: 30657933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors.
    Dermawan JKT; Farver CF
    Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung.
    Yang Z; Wang Z; Duan Y; Xu S
    Thorac Cancer; 2016 Nov; 7(6):633-638. PubMed ID: 27755793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver variability for the WHO classification of pulmonary carcinoids.
    Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ
    Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amine and peptide hormone production by lung carcinoid: a clinicopathological and immunocytochemical study.
    Bosman FT; de la Riviere AB; Giard RW; Verhofstad AA; Cramer-Knijnenburg G
    J Clin Pathol; 1984 Aug; 37(8):931-6. PubMed ID: 6147359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.
    Du EZ; Goldstraw P; Zacharias J; Tiffet O; Craig PJ; Nicholson AG; Weidner N; Yi ES
    Hum Pathol; 2004 Jul; 35(7):825-31. PubMed ID: 15257545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cyclin A2 and B1 expression in lung carcinoids.
    Brcic L; Heidinger M; Sever AZ; Zacharias M; Jakopovic M; Fediuk M; Maier A; Quehenberger F; Seiwerth S; Popper H
    Pathology; 2019 Aug; 51(5):481-486. PubMed ID: 31230818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification.
    Mezzetti M; Raveglia F; Panigalli T; Giuliani L; Lo Giudice F; Meda S; Conforti S
    Ann Thorac Surg; 2003 Dec; 76(6):1838-42. PubMed ID: 14667595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.
    Papaxoinis G; Nonaka D; O'Brien C; Sanderson B; Krysiak P; Mansoor W
    Endocr Pathol; 2017 Mar; 28(1):60-70. PubMed ID: 27873160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary carcinoid tumours: indolent but not benign.
    De Dosso S; Bajetta E; Procopio G; Cortinovis D; Buzzoni R; Catena L; Platania M; Verzoni E
    Oncology; 2007; 73(3-4):162-8. PubMed ID: 18418008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.